Today, Timmerman Traverse alum, LSC Boston Advisor and Nimbus Therapeutics CEO Jeb Keiper and his wife Sonja made a significant gift to propel the team closer to their goal of $1M.
“I have been so fortunate as a biotech leader and I recognize that is in large part because of the incredible support and dedication of my team— the team at Nimbus, my investors and board members, my peers. The Timmerman Traverse is a testament to the power of teamwork and as an alum, I am proud to support this year’s team as they climb to great heights,” Jeb said.
The Keipers’ gift puts the 2023 Timmerman Traverse team over $950,000 collected toward their team goal of $1 million. All of the money raised goes to support Life Science Cares’ mission of disrupting the cycle of poverty and inequity in the community.
Jeb participated in the inaugural Timmerman Traverse in 2021. He has been an LSC Boston Advisor and active volunteer since November 2018. When the pandemic hit, Jeb was one of a number of local industry leaders who rolled up their sleeves and collected PPE, clothing and other critical supplies, delivering donations to community partners directly.
“Giving back to our local community is part of the small biotech DNA, and Life Science Cares has enabled dozens and dozens of small biotechs to make a major impact on our community. My family and I wanted to provide a gift to expand and sustain LSC’s great work,” he said.
The 2023 Timmerman Traverse kicks off August 20th in the White Mountains. Each of the 20 participants—all life science leaders raising funds for one of LSC’s five affiliates—commit to raising at least $25,000 each. Meet the class of 2023 and contribute at https://timmermantraverse2023.blackbaud-sites.com/.